Mapping genetic modifiers of survival in a mouse model of Dravet syndrome

A. R. Miller, N. A. Hawkins, C. E. Mccollom, J. A. Kearney*

*Corresponding author for this work

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Epilepsy is a common neurological disorder affecting approximately 1% of the population. Mutations in voltage-gated sodium channels are responsible for several monogenic epilepsy syndromes. More than 800 mutations in the voltage-gated sodium channel SCN1A have been reported in patients with generalized epilepsy with febrile seizures plus and Dravet syndrome. Heterozygous loss-of-function mutations in SCN1A result in Dravet syndrome, a severe infant-onset epileptic encephalopathy characterized by intractable seizures, developmental delays and increased mortality. A common feature of monogenic epilepsies is variable expressivity among individuals with the same mutation, suggesting that genetic modifiers may influence clinical severity. Mice with heterozygous deletion of Scn1a (Scn1a+/-) model a number of Dravet syndrome features, including spontaneous seizures and premature lethality. Phenotype severity in Scn1a+/- mice is strongly dependent on strain background. On the 129S6/SvEvTac strain Scn1a+/- mice exhibit no overt phenotype, whereas on the (C57BL/6J × 129S6/SvEvTac)F1 strain Scn1a+/- mice exhibit spontaneous seizures and early lethality. To systematically identify loci that influence premature lethality in Scn1a+/- mice, we performed genome scans on reciprocal backcrosses. Quantitative trait locus mapping revealed modifier loci on mouse chromosomes 5, 7, 8 and 11. RNA-seq analysis of strain-dependent gene expression, regulation and coding sequence variation provided a list of potential functional candidate genes at each locus. Identification of modifier genes that influence survival in Scn1a+/- mice will improve our understanding of the pathophysiology of Dravet syndrome and may suggest novel therapeutic strategies for improved treatment of human patients.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalGenes, Brain and Behavior
Volume13
Issue number2
DOIs
StatePublished - Feb 1 2014

Fingerprint

Myoclonic Epilepsy
Survival
Voltage-Gated Sodium Channels
Epilepsy
Mutation
Seizures
Modifier Genes
Phenotype
Chromosomes, Human, Pair 5
Chromosomes, Human, Pair 11
Chromosomes, Human, Pair 7
Quantitative Trait Loci
Gene Expression Regulation
Brain Diseases
Nervous System Diseases
Genome
RNA
Mortality
Therapeutics

Keywords

  • Dravet syndrome
  • Epilepsy
  • Epileptic encephalopathy
  • Mouse model
  • RNA-seq
  • Seizures
  • Severe myoclonic epilepsy of infancy
  • Transcriptomics
  • Voltage-gated ion channels
  • Voltage-gated sodium channels

ASJC Scopus subject areas

  • Genetics
  • Neurology
  • Behavioral Neuroscience

Cite this

@article{503a3642eb46462885c6143a805f05a6,
title = "Mapping genetic modifiers of survival in a mouse model of Dravet syndrome",
abstract = "Epilepsy is a common neurological disorder affecting approximately 1{\%} of the population. Mutations in voltage-gated sodium channels are responsible for several monogenic epilepsy syndromes. More than 800 mutations in the voltage-gated sodium channel SCN1A have been reported in patients with generalized epilepsy with febrile seizures plus and Dravet syndrome. Heterozygous loss-of-function mutations in SCN1A result in Dravet syndrome, a severe infant-onset epileptic encephalopathy characterized by intractable seizures, developmental delays and increased mortality. A common feature of monogenic epilepsies is variable expressivity among individuals with the same mutation, suggesting that genetic modifiers may influence clinical severity. Mice with heterozygous deletion of Scn1a (Scn1a+/-) model a number of Dravet syndrome features, including spontaneous seizures and premature lethality. Phenotype severity in Scn1a+/- mice is strongly dependent on strain background. On the 129S6/SvEvTac strain Scn1a+/- mice exhibit no overt phenotype, whereas on the (C57BL/6J × 129S6/SvEvTac)F1 strain Scn1a+/- mice exhibit spontaneous seizures and early lethality. To systematically identify loci that influence premature lethality in Scn1a+/- mice, we performed genome scans on reciprocal backcrosses. Quantitative trait locus mapping revealed modifier loci on mouse chromosomes 5, 7, 8 and 11. RNA-seq analysis of strain-dependent gene expression, regulation and coding sequence variation provided a list of potential functional candidate genes at each locus. Identification of modifier genes that influence survival in Scn1a+/- mice will improve our understanding of the pathophysiology of Dravet syndrome and may suggest novel therapeutic strategies for improved treatment of human patients.",
keywords = "Dravet syndrome, Epilepsy, Epileptic encephalopathy, Mouse model, RNA-seq, Seizures, Severe myoclonic epilepsy of infancy, Transcriptomics, Voltage-gated ion channels, Voltage-gated sodium channels",
author = "Miller, {A. R.} and Hawkins, {N. A.} and Mccollom, {C. E.} and Kearney, {J. A.}",
year = "2014",
month = "2",
day = "1",
doi = "10.1111/gbb.12099",
language = "English (US)",
volume = "13",
pages = "163--172",
journal = "Genes, Brain and Behavior",
issn = "1601-1848",
publisher = "Wiley-Blackwell",
number = "2",

}

Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. / Miller, A. R.; Hawkins, N. A.; Mccollom, C. E.; Kearney, J. A.

In: Genes, Brain and Behavior, Vol. 13, No. 2, 01.02.2014, p. 163-172.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mapping genetic modifiers of survival in a mouse model of Dravet syndrome

AU - Miller, A. R.

AU - Hawkins, N. A.

AU - Mccollom, C. E.

AU - Kearney, J. A.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Epilepsy is a common neurological disorder affecting approximately 1% of the population. Mutations in voltage-gated sodium channels are responsible for several monogenic epilepsy syndromes. More than 800 mutations in the voltage-gated sodium channel SCN1A have been reported in patients with generalized epilepsy with febrile seizures plus and Dravet syndrome. Heterozygous loss-of-function mutations in SCN1A result in Dravet syndrome, a severe infant-onset epileptic encephalopathy characterized by intractable seizures, developmental delays and increased mortality. A common feature of monogenic epilepsies is variable expressivity among individuals with the same mutation, suggesting that genetic modifiers may influence clinical severity. Mice with heterozygous deletion of Scn1a (Scn1a+/-) model a number of Dravet syndrome features, including spontaneous seizures and premature lethality. Phenotype severity in Scn1a+/- mice is strongly dependent on strain background. On the 129S6/SvEvTac strain Scn1a+/- mice exhibit no overt phenotype, whereas on the (C57BL/6J × 129S6/SvEvTac)F1 strain Scn1a+/- mice exhibit spontaneous seizures and early lethality. To systematically identify loci that influence premature lethality in Scn1a+/- mice, we performed genome scans on reciprocal backcrosses. Quantitative trait locus mapping revealed modifier loci on mouse chromosomes 5, 7, 8 and 11. RNA-seq analysis of strain-dependent gene expression, regulation and coding sequence variation provided a list of potential functional candidate genes at each locus. Identification of modifier genes that influence survival in Scn1a+/- mice will improve our understanding of the pathophysiology of Dravet syndrome and may suggest novel therapeutic strategies for improved treatment of human patients.

AB - Epilepsy is a common neurological disorder affecting approximately 1% of the population. Mutations in voltage-gated sodium channels are responsible for several monogenic epilepsy syndromes. More than 800 mutations in the voltage-gated sodium channel SCN1A have been reported in patients with generalized epilepsy with febrile seizures plus and Dravet syndrome. Heterozygous loss-of-function mutations in SCN1A result in Dravet syndrome, a severe infant-onset epileptic encephalopathy characterized by intractable seizures, developmental delays and increased mortality. A common feature of monogenic epilepsies is variable expressivity among individuals with the same mutation, suggesting that genetic modifiers may influence clinical severity. Mice with heterozygous deletion of Scn1a (Scn1a+/-) model a number of Dravet syndrome features, including spontaneous seizures and premature lethality. Phenotype severity in Scn1a+/- mice is strongly dependent on strain background. On the 129S6/SvEvTac strain Scn1a+/- mice exhibit no overt phenotype, whereas on the (C57BL/6J × 129S6/SvEvTac)F1 strain Scn1a+/- mice exhibit spontaneous seizures and early lethality. To systematically identify loci that influence premature lethality in Scn1a+/- mice, we performed genome scans on reciprocal backcrosses. Quantitative trait locus mapping revealed modifier loci on mouse chromosomes 5, 7, 8 and 11. RNA-seq analysis of strain-dependent gene expression, regulation and coding sequence variation provided a list of potential functional candidate genes at each locus. Identification of modifier genes that influence survival in Scn1a+/- mice will improve our understanding of the pathophysiology of Dravet syndrome and may suggest novel therapeutic strategies for improved treatment of human patients.

KW - Dravet syndrome

KW - Epilepsy

KW - Epileptic encephalopathy

KW - Mouse model

KW - RNA-seq

KW - Seizures

KW - Severe myoclonic epilepsy of infancy

KW - Transcriptomics

KW - Voltage-gated ion channels

KW - Voltage-gated sodium channels

UR - http://www.scopus.com/inward/record.url?scp=84892997606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892997606&partnerID=8YFLogxK

U2 - 10.1111/gbb.12099

DO - 10.1111/gbb.12099

M3 - Article

C2 - 24152123

AN - SCOPUS:84892997606

VL - 13

SP - 163

EP - 172

JO - Genes, Brain and Behavior

JF - Genes, Brain and Behavior

SN - 1601-1848

IS - 2

ER -